Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

Table of Contents

April 1, 2021; Volume 62,Issue 4

Cover image

Cover image expansion

FEATURED ARTICLE

First-in-Humans Study of 68Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1. Riikka Viitanen et al. See page 577.

PRRT in treatment-resistant meningioma: a scientifi c overview of targeted peptide-receptor radionuclide therapy in this challenging setting. Christian Mirian et al. See page 507.

TSPO PET with 18F-LW223: developing 18-kDa translocator proteins to detect macrophage-driven inflammation in myocardial infarction. Mark MacAskill et al. See page 536.

Back to top
Previous

In this issue

Journal of Nuclear Medicine: 62 (4)
Journal of Nuclear Medicine
Vol. 62, Issue 4
April 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with 18F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism
  • First-in-Humans Study of 68Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1
  • Somatostatin Receptor–Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • The State of the Art
  • Continuing Education
  • Hot Topics
  • Focus on Molecular Imaging
  • Editorial
  • Oncology
    • Clinical
    • Translational
    • Basic
  • Theranostics
    • Clinical
      • FEATURED CLINICAL INVESTIGATION ARTICLE
    • Basic
  • AI/Advanced Image Analysis
    • Clinical
  • Cardiovascular
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Neurology
    • Clinical
    • Translational
  • Pediatrics
    • Clinical
      • INVITED PERSPECTIVE
  • Inflammation/Infection
    • Translational
      • FEATURED ARTICLE OF THE MONTH
  • Radiobiology/Dosimetry
    • Basic
  • Letters to the Editor
  • SNMMI Newsline
  • Most Cited
  • Most Read
Loading
  • 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
  • Deep Learning Analysis of Upright-Supine High-Efficiency SPECT Myocardial Perfusion Imaging for Prediction of Obstructive Coronary Artery Disease: A Multicenter Study
  • Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region
  • Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention
  • Diagnostic Evaluation of Pulmonary Embolism During the COVID-19 Pandemic
More...
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire